Creepy, Dreadful, Wonderful Viruses

Virtual Lecture

Originally posted: October 26, 2022 


In this month’s “Virtual Lecture,” Bobbi Pritt, M.D., shares a series of spooky tales to scare and amaze related to the discovery, characterization, and clinical presentation of notable viruses. 


Length of Video: 53 minutes


Bobbi Pritt, M.D.

Professor of Laboratory Medicine and Pathology
Division Chair, Clinical Microbiology
Department of Laboratory Medicine and Pathology
Mayo Clinic, Rochester, Minnesota

Learning objectives

Upon completion of this activity, participants should be able to:

  • Describe the discovery and characterization of certain notable viruses.
  • Discuss the clinical presentation of select viral infections.
  • State how creepy, dreadful, and wonderful viruses can be.

Intended audience

This program is appropriate for clinicians, pathologists, medical technologists, nurses, pharmacists, and other allied health staff.


The following types of credit are offered for this event:


Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 1.0 P.A.C.E.® contact hour.

State of Florida

Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for the Clinical Laboratory Sciences for the State of Florida. Florida Board of Clinical Laboratory Personnel has designated this program for General (Microbiology/Mycology/Parasitology) credit. This program has been approved for 1.0 contact hour.

To obtain credit

1. Watch the video.

2. Complete the post-test and evaluation that launches immediately following the video.

3. Generate and print your certificate(s).

Credit expires: October 26, 2024

Level of instruction for this program is basic.

Faculty disclosure

Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.


Contact us:

Image credit: Shutterstock/Pressmaster

MCL Education

This post was developed by our Education and Technical Publications Team.